Evaluation of circulating cell-free KRAS mutational status as a molecular monitoring tool in patients with pancreatic cancer.
Schlick K, Markus S, Huemer F, Ratzinger L, Zaborsky N, Clemens H, Neureiter D, Neumayer B, Beate AS, Florian S, Martin V, Grundbichler M, Weiss L, Melchardt T, Greil R, Egle A.
Schlick K, et al. Among authors: neumayer b.
Pancreatology. 2021 Dec;21(8):1466-1471. doi: 10.1016/j.pan.2021.09.004. Epub 2021 Sep 8.
Pancreatology. 2021.
PMID: 34511398
Free article.